BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Cell therapies hold life-saving potential for patients and the
  race is on to develop best-in-class\, living\, 'thinking' drugs. Relapse
  rates and barriers to solid tumor efficacy mean the cell therapy industr
 y must innovate\, now more than ever.\n\nDue to its successful first edit
 ion\, the Multi-Functional Cell Therapies Summit is returning for 2022 an
 d will be uniting global leaders to discuss strategies to weaponize cell 
 therapies with antigenic\, engineered\, and combination approaches to cre
 ate sophisticated multi-functional systems.\n\nView the full event brochu
 re here: https://ter.li/6o9ghc\n\nThe 2nd Annual Multi-Functional Cell Th
 erapies Summit remains the only cell-type agnostic\, targeting focused me
 eting providing a platform for overcoming the challenges to weaponizing c
 ell therapies against solid tumors such as:\n\n-Understanding and overcom
 ing the immunosuppressive nature of the TME to inform future drug develop
 ment-Exploiting multiple functions through innovative engineering and nov
 el targeting approaches to produce "smarter" cell therapies with high eff
 icacy and safety profiles-Synergizing analytical strategy with efficient 
 and standardized manufacturing to overcome regulatory barriers preventing
  approval&nbsp\;\n\nJoin us as we bring together drug developers and inno
 vators to tackle unique cell therapy development challenges creating obst
 acles for effective treatments for solid tumor patients.\n\nRegister for 
 your ticket here: https://ter.li/ntcd3z\n
DTEND:20220127T170000
DTSTAMP:20260512T230906Z
DTSTART:20220125T080000
LOCATION:Online\, \,
SEQUENCE:0
SUMMARY:Cell therapies hold life-saving potential for patients and the rac
 e is on to develop best-in-class\, living\, 'thinking' drugs. Relapse rat
 es and bar...
UID:c5e48f86-312f-470a-82da-9473234e35d8
END:VEVENT
END:VCALENDAR